Definitive Healthcare Corp. (DH) vs Polaryx Therapeutics, Inc. Common Stock (PLYX)
A side-by-side comparison of Definitive Healthcare Corp. and Polaryx Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DH
Definitive Healthcare Corp.
$1.00HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
PLYX
Polaryx Therapeutics, Inc. Common Stock
$2.12HealthcareDelayed quote: Oct 6, 2026, 1:43 PM EDT
Total return — DH vs PLYX
growth of $100 · dividends reinvested · last 1yDH -57.5% (-57.5%/yr)PLYX -94.1% (-94.1%/yr)DH compounded faster over this window
Log scale — wide-divergence pair
DH PLYX
DH vs PLYX: by the numbers
- •PLYX is the larger company ($106M vs $105M market cap).
- •Both run net losses; PLYX's is the smaller (0.00% vs -72.28% net margin).
Metrics side by side
Valuation
| Metric | DH | PLYX |
|---|---|---|
| Forward P/E | 5.11 | N/A |
| P/S ratio | 0.45 | N/A |
| P/B ratio | 0.73 | 9.66 |
| EV / EBITDA | 0.49 | N/A |
| FCF yield | 27.20% | N/A |
Profitability
| Metric | DH | PLYX |
|---|---|---|
| Gross margin | 71.67% | 0.00% |
| Operating margin | -8.52% | 0.00% |
| Net margin | -72.28% | 0.00% |
| ROE | -116.28% | -62.61% |
| ROIC | 41.64% | -47.75% |
Growth (annualized)
| Metric | DH | PLYX |
|---|---|---|
| Revenue CAGR (5Y) | 10.62% | N/A |
| FCF CAGR (5Y) | 2.14% | N/A |
| Total return CAGR (5Y) | -52.54% | N/A |
Go deeper
Dig into the metrics
Definitive Healthcare ROEPolaryx Therapeutics, Inc. Common Stock ROEDefinitive Healthcare operating marginPolaryx Therapeutics, Inc. Common Stock operating marginDefinitive Healthcare revenue growthPolaryx Therapeutics, Inc. Common Stock revenue growthDefinitive Healthcare free cash flowPolaryx Therapeutics, Inc. Common Stock free cash flow
Definitive Healthcare & Polaryx Therapeutics, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.